E854-1334 Screening compound: N-[(2,3-dimethoxyphenyl)methyl]-2-{3,4-dimethyl-7-oxo-2-phenyl-2H,6H,7H-pyrazolo[3,4-d]pyridazin-6-yl}propanamide

E854-1334 Screening compound: N-[(2,3-dimethoxyphenyl)methyl]-2-{3,4-dimethyl-7-oxo-2-phenyl-2H,6H,7H-pyrazolo[3,4-d]pyridazin-6-yl}propanamide
E854-1334 Screening compound: N-[(2,3-dimethoxyphenyl)methyl]-2-{3,4-dimethyl-7-oxo-2-phenyl-2H,6H,7H-pyrazolo[3,4-d]pyridazin-6-yl}propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E854-1334
N-[(2,3-dimethoxyphenyl)methyl]-2-{3,4-dimethyl-7-oxo-2-phenyl-2H,6H,7H-pyrazolo[3,4-d]pyridazin-6-yl}propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E854-1334

Molecular Formula

C25H27N5O4 (C25 H27 N5 O4)

Compound Name

N-[(2,3-dimethoxyphenyl)methyl]-2-{3,4-dimethyl-7-oxo-2-phenyl-2H,6H,7H-pyrazolo[3,4-d]pyridazin-6-yl}propanamide

IUPAC name

N-[(23-dimethoxyphenyl)methyl]-2-{34-dimethyl-7-oxo-2-phenyl-2H6H7H-pyrazolo[34-d]pyridazin-6-yl}propanamide

SMILES

CC(C(NCc(cccc1OC)c1OC)=O)N1N=C(C)c2c(C)n(-c3ccccc3)nc2C1=O

InChI

InChI=1S/C25H27N5O4/c1-15-21-16(2)29(19-11-7-6-8-12-19)28-22(21)25(32)30(27-15)17(3)24(31)26-14-18-10-9-13-20(33-4)23(18)34-5/h6-13,17H,14H2,1-5H3,(H,26,31)/t17-/m0/s1

InChI Key

AVVYWXVKVFCTNY-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD14922833

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

461.52

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.794

Distribution Coefficient, logD

2.794

Water Solubility, LogSw

-3.21

Polar Surface Area

79.908

Acid Dissociation Constant (pKa)

13.85

Base Dissociation Constant (pKb)

-0.03

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.00

E854-1334 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with E854-1334 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E854-1334?
Check Price and Availability of E854-1334, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E854-1334 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E854-1334
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E854-1334
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E854-1334 available by request